Ursodeoxycholic acid - The therapeutic success?;Kwas ursodeoksycholowy - Sukces terapeutyczny leku?

Gastroenterologia Polska

Volumn 8, Issue 1, 2001, Pages 73-78

  Kiluk, A ^a   Romatowski, J A ^a  

^a Wojewodzki Szpital Zespolony   (Poland)

Author keywords

Bile acids; Cholestasis; Ursodeoxycholic acid

Indexed keywords

TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

BILE SECRETION; CHOLESTASIS; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; GALLSTONE; GASTRITIS; HUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW;

EID: 0034844709     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid
2. Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis
3. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid
4. Enrichment of the more hydrophilic bile ursodeoxycholic acid in the fecal water-soluble fraction after feeding rats with colon polyps
5. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial
6. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease
7. Ursodeoxycholic acid treatment in patient with primary biliary cirrhosis
8. Ursodeoxycholic acid treatment of refractory chronic graft-versus host disease of the liver
9. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
10. Pharmacology of ursodeoxycholic acid, an enterohepatic drug
11. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone
12. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patient with primary biliary cirrhosis
13. Wpływ leczenia kwasem ursodezoksycholowym na stȩżnie bilirubiny i przeżycie chorych z pierwotna̧ marskościa̧ wa̧troby
14. Ursodiol for primary sclerosing cholangitis
15. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
16. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patient with primary biliary cirrhosis
17. Reflux gastritis syndrome
18. Ursodeoxycholic acid for treatment of androgen-induced cholestasis
19. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: A randomized, double-blind study controlled with placebo
20. Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: Results of a randomized, double-blind, placebo-controlled trial
21. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis
22. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse
23. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: A comparison with ursodeoxycholic acid alone
24. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
25. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
26. Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy
27. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta
28. Bile lithogenicity and gallbladder emptying in patient with microlithiasis: Effect of bile acid therapy
29. Ursodeoxycholic acid treatment of bile reflux gastritis
30. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patient with cholesterol gallstones
31. Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?
32. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis
33. Membrane cholesterol alters gallbladder muscle contractility in prairie dogs